Amy Perniciaro

Amy Perniciaro is the Global VP of Clinical Operations at Beacon Therapeutics, with previous experience as a Clinical Operations Consultant and Vice President at various biotech and pharma companies. Amy has extensive experience leading clinical operations for global ophthalmology and rare disease gene therapy programs, as well as overseeing clinical trials in rare diseases such as nmDMD, Aniridia, and Dravet Syndrome. Amy has a BA in Biology & Psychology from Rutgers University.